BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18363277)

  • 1. Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma.
    Lee Y; Lee KW; Kim JH; Bang SM; Lee JS; Park BB; Kim WS; Suh C; Kang JH; Ryoo BY; Lee JH; Shin DB
    Korean J Intern Med; 2008 Mar; 23(1):30-6. PubMed ID: 18363277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma.
    Kawano R; Ohshima K; Wakamatsu S; Suzumiya J; Kikuchi M; Tamura K
    Haematologica; 2005 Sep; 90(9):1192-6. PubMed ID: 16154842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
    Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of angioimmunoblastic T-cell lymphomas (AILT) and its association with Epstein-Barr virus (EBV) in Pakistani patients.
    Noorali S; Nasir MI; Pervez S
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):404-8. PubMed ID: 16197868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma.
    Ohshima K; Takeo H; Kikuchi M; Kozuru M; Uike N; Masuda Y; Yoneda S; Takeshita M; Shibata T; Akamatsu M
    Histopathology; 1994 Dec; 25(6):569-79. PubMed ID: 7698734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
    d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
    Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
    Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A
    Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
    Brown HA; Macon WR; Kurtin PJ; Gibson LE
    J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas.
    Chen YP; Jones D; Chen TY; Chang KC
    Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type.
    Lee J; Suh C; Huh J; Jun HJ; Kim K; Jung C; Park K; Park YH; Ko YH; Kim WS
    Clin Cancer Res; 2007 Jun; 13(11):3250-4. PubMed ID: 17545530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features.
    Lee WJ; Won KH; Choi JW; Won CH; Chang SE; Choi JH; Lee MW
    J Am Acad Dermatol; 2019 Oct; 81(4):989-997. PubMed ID: 30240776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan.
    Hirose Y; Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawabata H; Fukushima T; Ogawa N; Wano Y; Umehara H
    Eur J Haematol; 2006 Feb; 76(2):109-18. PubMed ID: 16405431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature.
    Xu Y; McKenna RW; Hoang MP; Collins RH; Kroft SH
    Am J Clin Pathol; 2002 Dec; 118(6):848-54. PubMed ID: 12472277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas.
    Jung CK; Lee KY; Kim Y; Han K; Shim SI; Kim BK; Kang CS
    Pathol Int; 2001 May; 51(5):355-63. PubMed ID: 11422793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus.
    Nakamura S; Sasajima Y; Koshikawa T; Kitoh K; Koike K; Motoori T; Ueda R; Mori S; Suchi T
    Pathol Int; 1995 Dec; 45(12):958-64. PubMed ID: 8808302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy.
    Borisch B; Caioni M; Hurwitz N; Dommann-Scherrer C; Odermatt B; Waelti E; Laeng RH; Kraft R; Laissue J
    Int J Cancer; 1993 Nov; 55(5):748-52. PubMed ID: 8244571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus in angioimmunoblastic T-cell lymphomas.
    Khan G; Norton AJ; Slavin G
    Histopathology; 1993 Feb; 22(2):145-9. PubMed ID: 8384155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-encoded RNA1-positive cells in the bone marrow specimens of patients with EBV-negative lymphomas and sarcomas.
    Ito Y; Makita S; Maeshima AM; Hatta S; Yuda S; Suzuki T; Fukuhara S; Munakata W; Taniguchi H; Suzuki T; Maruyama D; Izutsu K
    Pathol Int; 2019 Jul; 69(7):392-397. PubMed ID: 31328350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
    Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
    Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.
    Bräuninger A; Spieker T; Willenbrock K; Gaulard P; Wacker HH; Rajewsky K; Hansmann ML; Küppers R
    J Exp Med; 2001 Oct; 194(7):927-40. PubMed ID: 11581315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.